Related Experiment Video
Updated: May 7, 2026
Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish
Published on: April 25, 2017
Zebrafish cancer and metastasis models for in vivo drug discovery
Abstract:
There is a great need for more efficient methods to discover new cancer therapeutics, as traditional drug development processes are slow and expensive. The use of zebrafish as a whole-organism screen is a time and cost-effective means of improving the efficiency and efficacy of drug development. This review features zebrafish genetic and cell transplantation models of cancer and metastasis, and current imaging and automation technologies that, together, will significantly advance the field of anti-cancer drug discovery.
Insights
Zebrafish models offer a faster, cheaper way to find new cancer drugs. Combining genetic models, cell transplantation, and advanced imaging accelerates anti-cancer drug discovery.
Area of Science:
- Oncology
- Drug Discovery
- Zebrafish Models
Background:
- Traditional cancer therapeutic development is slow and costly.
- There is a significant need for more efficient drug discovery methods.
Purpose of the Study:
- To review the utility of zebrafish as a whole-organism screening platform for cancer therapeutics.
- To highlight advancements in zebrafish cancer models and imaging technologies.
Main Methods:
- Review of genetic and cell transplantation zebrafish models of cancer and metastasis.
- Discussion of current imaging and automation technologies applicable to zebrafish screening.
Main Results:
- Zebrafish models provide a time- and cost-effective approach to drug screening.
- Integrated technologies significantly enhance the efficiency of anti-cancer drug discovery.
Conclusions:
- Zebrafish platforms are poised to revolutionize anti-cancer drug discovery.
- The combination of models and technology accelerates the identification of novel therapeutics.
